Supportive Care and CD34+ Cell Count Reinfused
| Parameters . | All Patients (n = 168) . | CD34+ Cell Dose (×106/kg) . | ||
|---|---|---|---|---|
| ≤2.5 (n = 22) . | >2.5 and <15 (n = 105) . | ≥15 (n = 41) . | ||
| Median no. of red blood cell transfusions | 2 | 4 | 2 | 2 |
| Range | 0-16 | 0-16 | 0-14 | 0-6 |
| Median no. of platelet transfusions | 2 | 3* | 2 | 1* |
| Range | 0-12 | 1-12 | 0-11 | 0-3 |
| Median days with antibiotics | 10 | 12* | 10 | 9 |
| Range | 3-47 | 8-35 | 3-47 | 6-23 |
| Median days of hospitalization | 14 | 17* | 14 | 13* |
| Range | 10-52 | 11-41 | 11-52 | 10-41 |
| Parameters . | All Patients (n = 168) . | CD34+ Cell Dose (×106/kg) . | ||
|---|---|---|---|---|
| ≤2.5 (n = 22) . | >2.5 and <15 (n = 105) . | ≥15 (n = 41) . | ||
| Median no. of red blood cell transfusions | 2 | 4 | 2 | 2 |
| Range | 0-16 | 0-16 | 0-14 | 0-6 |
| Median no. of platelet transfusions | 2 | 3* | 2 | 1* |
| Range | 0-12 | 1-12 | 0-11 | 0-3 |
| Median days with antibiotics | 10 | 12* | 10 | 9 |
| Range | 3-47 | 8-35 | 3-47 | 6-23 |
| Median days of hospitalization | 14 | 17* | 14 | 13* |
| Range | 10-52 | 11-41 | 11-52 | 10-41 |
*P < .05 compared with the intermediate CD34+ group using the Mann-Whitney U test.